Lv4
670 积分 2024-11-21 加入
A Review of Conjugation Technologies for Antibody Drug Conjugates
1天前
已完结
Abstract 7292: HY05350: A trispecific T-cell engager with immune checkpoint inhibitor targeting mesothelin for solid cancer
22天前
已关闭
Antibody–drug conjugates: Recent advances in payloads
22天前
已完结
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 2: Synthesis of the Payload, Linker, and Drug Linker
1个月前
已完结
Productivity enhancement of recombinant protein in CHO cells via specific promoter activation by oncogenes
1个月前
已完结
A Review of Conjugation Technologies for Antibody Drug Conjugates
1个月前
已完结
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
1个月前
已完结
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies
1个月前
已完结
Overview of antibody-drug conjugates nonclinical and clinical toxicities and related contributing factors
2个月前
已完结
Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activity
2个月前
已完结
皖公网安备34019202002308
